Welcome to Thom Gambino’s World
Welcome to Thom Gambino’s World
Welcome to Thom Gambino’s World
Reports say AI adoption is ‘surging’ among small businesses. But these likely inflated claims help boost their brands
Three lighthouse use cases serve as a blueprint for AI’s potential to improve the speed, efficiency, and quality of clinical trials.
Background Lifestyle change plays a crucial role in the prevention and treatment of metabolic dysfunction-associated steatotic liver disease (MASLD). In recent years, diet soft drinks…
Nature – Experimental model’s record-breaking performance on science and maths tests wows researchers.
The agency issued designs for front-of-package lists that food companies would be required to include.
With a tool often used in the study of dinosaur fossils, scientists uncovered new details in ornate tattoos on the skin of members of the…
Revenue for the blockbuster Eli Lilly drugs Mounjaro and Zepbound continues to grow, but not as much as expected. At the J.P. Morgan Healthcare Conference,…
Outbreaks among the unvaccinated are a predictable consequence of falling immunization rates. But even vaccinated adults may be vulnerable to some illnesses.
An up-to-date overview of the ESC’s 2024 guidance on peripheral arterial and aortic diseases, including comparison with NICE, ESVS, and UK screening guidance
The latest global news and analysis in payments, retail, fintech, financial services and the digital economy.